Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | TOP2A | P11388 | 6/20 | 0.38 |
| ▸ | TOP2B | Q02880 | 6/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3262576 | 0.83 | KDM4E (0.41) | ADRB2ALDH1A1KDM4ECYP1A2TOP2A | |
| SCHEMBL3131995 | 0.83 | ADRB2 (0.46) | ADRB2POLBALDH1A1CHRM2CHRM1 | |
| SCHEMBL2184241 | 0.76 | ADRB2 (0.51) | ADRB2POLBALDH1A1CHRM2CHRM1 | |
| SCHEMBL27629820 | 0.74 | ALDH1A1 (0.46) | ADRB2POLBALDH1A1CHRM2CHRM1 | |
| SCHEMBL3129389 | 0.74 | KDM4E (0.51) | ADRB2POLBALDH1A1OPRM1KDM4E | |
| SCHEMBL13823486 | 0.73 | KCNH2 (0.48) | ADRB2POLBALDH1A1CHRM2CHRM1 | |
| SCHEMBL4717958 | 0.73 | KDM4E (0.57) | POLBALDH1A1CHRM2CHRM1OPRM1 | |
| SCHEMBL29433780 | 0.73 | KDM4E (0.57) | POLBALDH1A1CHRM2CHRM1OPRM1 | |
| SCHEMBL3137596 | 0.73 | ADRB2 (0.44) | ADRB2POLBALDH1A1CHRM2CHRM1 | |
| SCHEMBL13790031 | 0.73 | KDM4E (0.49) | ADRB2POLBALDH1A1CHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090156577-A1 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | JANSSEN PHARMACEUTICA NV (BE) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156577-A1 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | NQO2, QRFPR, NQO1 | ADRB2 616/4885POLB 1377/4885ALDH1A1 1307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.